A phase 2a randomized, double‐blind, placebo‐controlled, sequential dose‐escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate‐to‐severe psoriasis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 767-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 2a randomized, double‐blind, placebo‐controlled, sequential dose‐escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate‐to‐severe psoriasis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 767-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of nortriptyline in functional dyspepsia in Asians: A randomized double‐blind placebo‐controlled trial

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 2, 2018-02 ,pp. : 411-417

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized double‐blind placebo‐controlled crossover‐style trial of buspirone in functional dysphagia and ineffective esophageal motility

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 30, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial

By Boureau F.   Legallicier P.   Kabir-Ahmadi M.  

Pain, Vol. 104, Iss. 1, 2003-07 ,pp. : 323-331

Elsevier

Access to resources Recommend Favorite